WLBHF is a non-profit organization whose major goal is to foster discoveries in pediatric acute lymphocytic leukemia with a goal of developing effective therapies for the disease. Applicants must either be an established investigator with an association to an academic institution or must be working closely and part of a lab working with an established investigator.
Grant applications should be no greater than 7 pages (Abstract, Background, Experimental Design, Expected Results, Potential Problems. Please use: Point 10 fond, Arial, single spaced). Also include References, detailed Timeline, Budget Justification, Other Support and Biosketch (NIH format). Last year, 14 grants were awarded; emphasis was placed on the translational merits of the proposal.
Priority will be given to those grants that have a translational bent getting new therapies to children with leukemias. Further areas of studies would be to identify new targets that could be utilized for therapy.
Funding: Direct cost for grants are limited to $150,000/year (direct costs). Grants are reviewed on a yearly basis and those that are funded and meet their milestones may be renewed on a yearly basis for up to 2 subsequent years. Indirect costs are limited to 10% per year. Initial grant will be funded for one year.
Review of grant: All applicants are reviewed by the grant committee and final approval rest with the Board of Directors. Awarding of the grant is based on the priority score and the availability of funds.
Send grants electronically to ( This e-mail address is being protected from spambots. You need JavaScript enabled to view it ). H. Phillip Koeffler, M.D., Director, Hematology/Oncology Division, Cedars-Sinai Medical Center, 8700 Beverly Blvd., AC1060, Los Angeles, CA 90048.
Grant deadline: September 16, 2010, no late applications. Notification of funding decision should occur by about November 16, 2010. Funding should begin shortly after the decision has been made.